Select Medical (SEM)
(Delayed Data from NYSE)
$33.70 USD
+0.56 (1.69%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $33.68 -0.02 (-0.06%) 7:58 PM ET
5-Strong Sell of 5 5
B Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$33.70 USD
+0.56 (1.69%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $33.68 -0.02 (-0.06%) 7:58 PM ET
5-Strong Sell of 5 5
B Value A Growth B Momentum A VGM
Zacks News
Centene (CNC) Divests IlliniCare as Part of Merger Agreement
by Zacks Equity Research
Centene (CNC) inks a deal to divest IlliniCare to CVS Health to facilitate the pre-announced merger agreement.
Why Should You Hold Centene (CNC) Stock in Your Portfolio?
by Zacks Equity Research
Acquisitions, rising revenues, growing membership and solid capital position carve out a long-term growth story for Centene (CNC).
Are Investors Undervaluing Select Medical (SEM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Magellan Health's PBM Division Unveils Care Management Plan
by Zacks Equity Research
Magellan Health's (MGLN) pharmacy benefit management division's newly-launched plan is expected to drive value-added healthcare.
Humana, Epione Tie Up to Aid Medicare Advantage Members
by Zacks Equity Research
Humana (HUM) inks deal with Epione Health of Oklahoma to provide better patient care.
UnitedHealth Group to Enhance its Medicare Advantage Network
by Zacks Equity Research
UnitedHealth Group (UNH) partners Walgreens to provide better access to MA members.
Why is HCA Healthcare an Attractive Stock for Your Portfolio?
by Zacks Equity Research
Growing revenues and a strong capital position bode well for HCA Healthcare (HCA).
The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical
Why Should You Hold Universal Health in Your Portfolio?
by Zacks Equity Research
Banking on its growing top line and strong segments, Universal Health (UHS) holds potential to reap benefits for investors.
Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD
by Sweta Killa
Healthcare bounced back with an outperformance starting the fourth quarter.
Humana (HUM) to Boost Medicare Advantage Network in Hawaii
by Zacks Equity Research
Humana (HUM) teams up with Hawaii Senior Medical Group to enrich patient experience of Medicare Advantage members in the region.
Humana (HUM) Scales New 52-Week High on Solid Q3 Earnings
by Zacks Equity Research
Humana (HUM) reaches a 52-week high, backed by strong-third-quarter results and Medicare business.
UnitedHealth (UNH) Looks Good: Stock Adds 5.3% in Session
by Zacks Equity Research
UnitedHealth (UNH) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
The Zacks Analyst Blog Highlights: McGrath RentCorp, FTI Consulting, Huron Consulting, Select Medical and Tenet Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: McGrath RentCorp, FTI Consulting, Huron Consulting, Select Medical and Tenet Healthcare
ISM Services Index Rebounds in October: 5 Top-Ranked Picks
by Nalak Das
The ISM Services index clearly reflects that the U.S. economy has sustained its momentum despite lingering trade conflict and global economic slowdown.
Select Medical (SEM) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of 50.00% and 4.64%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Select Medical (SEM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Select Medical (SEM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Select Medical (SEM) Matches Q4 Earnings Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of 0.00% and -0.92%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Select Medical (SEM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Weakness Seen in Select Medical Holdings (SEM) Estimates: Should You Stay Away?
by Zacks Equity Research
Select Medical Holdings (SEM) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Select Medical (SEM) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of 27.78% and 0.12%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Select Medical (SEM) Q3 Earnings Preview: What's Shaping Up?
by Zacks Equity Research
Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Select Medical (SEM) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of -13.89% and -0.57%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Select Medical (SEM) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Select Medical's (SEM) first-quarter results find support in bottom-line growth, higher revenues and solid segmental performances. However, rise in expenses is a downside.